Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort.

OBJECTIVES Examine the demographic and historical characteristics of a large Parkinson's disease (PD) clinical cohort and determine the pattern and relationship between initial symptoms of PD and physical examination ratings at the initial subspecialty clinic visit. METHODS A clinical series of 1244 consecutive individuals diagnosed with PD. Baseline characteristics were examined. RESULTS The overall sample was predominantly right-handed (92%) male (67%), with a mean age of 70 years and symptomatic disease duration of about 7 years. About 25% of the sample reported a positive family history of a neurodegenerative disorder. Tremor (47%) and bradykinesia (29%) were the two most common initial symptoms of PD and occurred primarily in the upper extremities (68%). Tremor, bradykinesia, and postural instability showed a significant correspondence between the initial self-reported symptom and clinical signs at the first exam p < 0.05. However, rigidity did not show a significant correspondence. CONCLUSION The demographic and clinical characteristics of the sample are thought to be phenotypically representative of 'typical' PD and were comparable to other clinic- and population-based cohorts. Initial symptoms reported by patients, including type and body location correlate tightly with initial examination findings for all cardinal symptoms of parkinsonism except rigidity. This corroboration may substantiate inclusion of such data in studies of longitudinal progression in PD.

[1]  Ward Cd,et al.  Research diagnostic criteria for Parkinson's disease. , 1990 .

[2]  A Hofman,et al.  Prevalence of Parkinson's disease in the elderly , 1995, Neurology.

[3]  N P Quinn,et al.  What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[4]  C. Tanner,et al.  Epidemiology of Parkinson's disease and akinetic syndromes , 2000, Current opinion in neurology.

[5]  P. Krack,et al.  Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. , 2001, The New England journal of medicine.

[6]  D. Maraganore,et al.  A population perspective on diagnostic criteria for Parkinson's disease , 1997, Neurology.

[7]  R. Uitti,et al.  “Familial Parkinson's Disease” – A Case-Control Study of Families , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  M. Adena,et al.  Age at onset: the major determinant of outcome in Parkinson's disease , 1995, Acta neurologica Scandinavica.

[9]  Nandini Dendukuri,et al.  Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. , 2003, The American journal of psychiatry.

[10]  M Richards,et al.  Interrater reliability of the unified Parkinson's disease rating scale motor examination , 1994, Movement disorders : official journal of the Movement Disorder Society.

[11]  Y Ben-Shlomo,et al.  The epidemiology of Parkinson's disease. , 1997, Bailliere's clinical neurology.

[12]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[13]  J. Jankovic,et al.  Functional decline in Parkinson disease. , 2001, Archives of neurology.

[14]  D. C. Howell Statistical Methods for Psychology , 1987 .

[15]  J. Jankovic,et al.  The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. , 2000, Archives of neurology.

[16]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[17]  Z. Schwab,et al.  Projection technique for evaluating surgery in Parkinson’s disease , 1969 .

[18]  A. Rajput Environmental toxins accelerate Parkinson’s disease onset , 2001, Neurology.

[19]  A. Rajput,et al.  Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[20]  E. Moro,et al.  Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease , 1999, Neurology.

[21]  J. Turner Third Symposium on Parkinson's Disease , 1970 .

[22]  D. Schaid,et al.  Validity of family history data on PD , 2003, Neurology.

[23]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[24]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .

[25]  T. Rummans,et al.  Evaluation and management of geriatric depression in primary care. , 2003, Mayo Clinic proceedings.

[26]  J. Cummings,et al.  Depression in patients with Parkinson's disease , 1999, International journal of geriatric psychiatry.

[27]  K. Marder,et al.  Progression of parkinsonian signs in Parkinson disease. , 1999, Archives of neurology.

[28]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[29]  J. Obeso,et al.  Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. , 2000, Neurology.

[30]  W. Hacke,et al.  Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus , 2001, Journal of neurology, neurosurgery, and psychiatry.

[31]  C. Tzourio,et al.  Familial aggregation of Parkinson’s disease , 1999, Neurology.

[32]  A. Siderowf,et al.  Parkinson's disease: clinical features, epidemiology and genetics. , 2001, Neurologic clinics.